Document is current
Any future updates will be listed below
-
Authors
Saloner, Brendan
Sugarman, Olivia K.
Byrne, Lauren
Harris, Samantha
Reid, Molly C.
Shah, Hridika
Hulsey, Eric
Hurst, Adrienne
Kerins, Lindsey
King, Dionna
Sherman, Susan
Kaner, Emily
Heller, Daliah
Bandara, Sachini
-
Funding
Funding for this research was provided by:
Bloomberg Philanthropies (NA)
- License Information
-
More Information
Article History
Received: 17 August 2024
Accepted: 13 November 2024
First Online: 20 November 2024
Declarations
:
: This research was reviewed and approved by the Johns Hopkins Bloomberg School of Public Health Institutional Review Board.
: All authors granted consent for publication. The interview guide for this study can be found in the appendix. Drs. Sherman and Saloner serve as expert witnesses on behalf of Baltimore City in its litigation against opioid manufacturers and distributors. The authors received support from the Bloomberg Philanthropies as part of The Bloomberg Overdose Prevention Initiative, a collaborative partnership aimed at combating the nation’s opioid epidemic.
: Drs. Sherman and Saloner serve as expert witnesses on behalf of Baltimore City in its litigation against opioid manufacturers and distributors.
